BriaCell Therapeutics Corp. (BCTX) vs Incannex Healthcare Limited (IXHL)
A side-by-side comparison of BriaCell Therapeutics Corp. and Incannex Healthcare Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BCTX
BriaCell Therapeutics Corp.
$4.09HealthcareDelayed quote: Oct 6, 2026, 11:57 AM EDT
IXHL
Incannex Healthcare Limited
$3.21HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT
Total return — BCTX vs IXHL
growth of $100 · dividends reinvested · last 5yBCTX -99.6% (-67.5%/yr)IXHL -99.8% (-71.8%/yr)BCTX compounded faster over this window
BCTX IXHL
BCTX vs IXHL: by the numbers
- •IXHL is the larger company ($38M vs $36M market cap).
Metrics side by side
Valuation
| Metric | BCTX | IXHL |
|---|---|---|
| P/B ratio | 1.48 | 0.57 |
Profitability
| Metric | BCTX | IXHL |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -154.06% | -28.65% |
| ROIC | -164.58% | -32.18% |
Growth (annualized)
| Metric | BCTX | IXHL |
|---|---|---|
| Total return CAGR (5Y) | -67.32% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.